Whitehawk Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-12.4M | $4.5M |
| FY2021 | — | $136.4M | $149.0M |
| FY2022 | — | $158.4M | $39.0M |
| FY2023 | — | $105.2M | $62.9M |
| FY2024 | — | $52.5M | $28.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-12.4M | $4.5M |
| FY2021 | — | $136.4M | $149.0M |
| FY2022 | — | $158.4M | $39.0M |
| FY2023 | — | $105.2M | $62.9M |
| FY2024 | — | $52.5M | $28.7M |